Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas - a tissue microarray study utilizing E6/E7 mRNA in situ hybridization

Histopathology

Volumn 60, Issue 6, 2012, Pages 982-991

  Lewis, James S ^a,b   Ukpo, Odey C ^a   Ma, Xiao Jun ^c   Flanagan, John J ^c   Luo, Yuling ^c   Thorstad, Wade L ^a   Chernock, Rebecca D ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Advanced Cell Diagnostics   (United States)

Author keywords

Human papillomavirus; In situ hybridization; Larynx; Oral cavity; Squamous cell carcinoma

Indexed keywords

MESSENGER RNA; PROTEIN P16; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TRANSCRIPTION INITIATION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IN SITU HYBRIDIZATION; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84863411099     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04169.x     Document Type: Article

References (46)

1. Lewin F, Norell SE, Johansson H et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998; 82; 1367-1375.
2. Lee JJ, Jeng JH, Wang HM et al. Univariate and multivariate analysis of prognostic significance of betel quid chewing in squamous cell carcinoma of buccal mucosa in Taiwan. J. Surg. Oncol. 2005; 91; 41-47.
3. Skarsgard DP, Groome PA, Mackillop WJ et al. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer 2000; 88; 1728-1738.
4. Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head and Neck Pathol. 2009; 3; 186-194.
5. Reimers N, Kasper HU, Weissenborn SJ et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int. J. Cancer 2007; 120; 1731-1738.
6. Nasman A, Attner P, Hammarstedt L et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int. J. Cancer 2009; 125; 362-366.
7. Adelstein DJ, Ridge JA, Gillison ML et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck 2009; 31; 1393-1422.
8. Ang KK, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2011; 363; 24-35.
9. Lewis JS Jr, Thorstad WL, Chernock RD et al. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favourable prognosis regardless of tumour HPV status. Am. J. Surg. Pathol. 2011; 34; 1088-1096.
10. Duray A, Descamps G, Arafa M et al. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int. J. Oncol. 2011; 39; 51-59.
11. Machado J, Reis PP, Zhang T et al. Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 2010; 2; 6.
12. Ribeiro KB, Levi JE, Pawlita M et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int. J. Epidemiol. 2011; 40; 489-502.
13. Schlecht NF, Brandwein-Gensler M, Nuovo GJ et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod. Pathol. 2011; 24; 1295-1305.
14. Angiero F, Gatta LB, Seramondi R et al. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer. Anticancer Res. 2010; 30; 3435-3440.
15. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2001; 91; 622-635.
16. Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M. Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol. J. 2010; 7; 253.
17. Deng Z, Hasegawa M, Matayoshi S et al. Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan. Eur. Arch. Otorhinolaryngol. 2011; 268; 1625-1631.
18. Laco J, Vosmikova H, Novakova V et al. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases. Virchows Arch. 2011; 458; 179-187.
19. Lee SY, Cho NH, Choi EC et al. Relevance of human papilloma virus (HPV) infection to carcinogenesis of oral tongue cancer. Int. J. Oral Maxillofac. Surg. 2010; 39; 678-683.
20. Soares RC, Oliveira MC, Souza LB, Costa AL, Medeiros SR, Pinto LP. Human papillomavirus in oral squamous cells carcinoma in a population of 75 Brazilian patients. Am. J. Otolaryngol. 2007; 28; 397-400.
21. Zhao D, Xu QG, Chen XM, Fan MW. Human papillomavirus as an independent predictor in oral squamous cell cancer. Int. J. Oral. Sci. 2009; 1; 119-125.
22. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J. Clin. Virol. 2005; 32(Suppl 1); S59-66.
23. Scapoli L, Palmieri A, Rubini C et al. Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Mod. Pathol. 2009; 22; 366-372.
24. Braakhuis BJ, Snijders PJ, Keune WJ et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J. Natl Cancer Inst. 2004; 96; 998-1006.
25. Gungor A, Cincik H, Baloglu H, Cekin E, Dogru S, Dursun E. Human papilloma virus prevalence in laryngeal squamous cell carcinoma. J. Laryngol. Otol. 2007; 121; 772-774.
26. Ma XL, Ueno K, Pan ZM, Hi SZ, Ohyama M, Eizuru Y. Human papillomavirus DNA sequences and p53 over-expression in laryngeal squamous cell carcinomas in Northeast China. J. Med. Virol. 1998; 54; 186-191.
27. Torrente MC, Rodrigo JP, Haigentz M Jr. et al. Human papillomavirus infections in laryngeal cancer. Head Neck 2011; 33; 581-586.
28. Baumann JL, Cohen S, Evjen AN et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope 2009; 119; 1531-1537.
29. Laco J, Slaninka I, Jirasek M, Celakovsky P, Vosmikova H, Ryska A. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions. Pathol. Res. Pract. 2008; 204; 545-552.
30. Yang SW, Lee YS, Chen TA, Wu CJ, Tsai CN. Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation. Cancer Epidemiol. 2009; 33; 118-122.
31. Bozdayi G, Kemaloglu Y, Ekinci O et al. Role of human papillomavirus in the clinical and histopathological features of laryngeal and hypopharyngeal cancers. J. Otolaryngol. Head Neck Surg. 2009; 38; 119-125.
32. Pintos J, Black MJ, Sadeghi N et al. Human papillomavirus infection and oral cancer: a case-control study in Montreal Canada. Oral Oncol. 2008; 44; 242-250.
33. Pintos J, Franco EL, Black MJ, Bergeron J, Arella M. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 1999; 85; 1903-1909.
34. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int. J. Cancer 2007; 121; 1813-1820.
35. Clayman GL, Stewart MG, Weber RS, el-Naggar AK, Grimm EA. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch. Otolaryngol. Head Neck Surg. 1994; 120; 743-748.
36. Morshed K, Polz-Dacewicz M, Szymanski M, Polz D. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur. Arch. Otorhinolaryngol. 2008; 265(Suppl 1); S89-96.
37. Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High risk human papillomaviru E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am. J. Surg. Pathol. 2011; 35; 1343-1350.
38. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011; 11; 9-22.
39. Westra W. The changing face of head and neck cancer in the 21st Century: the Impact of HPV on the epidemiology and pathology of oral cancer. Head and Neck Pathol. 2009; 3; 78-81.
40. Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2008; 14; 366-369.
41. El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006; 101; 339-345.
42. Masand RP, El-Mofty SK, Ma XJ, Luo Y, Flanagan JJ, Lewis JS Jr. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011; 137; 108-116.
43. Chernock RD, Lewis JS Jr, Zhang Q, El-Mofty SK. Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathological and molecular subtype of basaloid squamous cell carcinoma. Hum. Pathol. 2010; 41; 1016-1023.
44. Mendelsohn AH, Lai CK, Shintaku IP et al. Histopathological findings of HPV and p16 positive HNSCC. Laryngoscope 2010; 120; 1788-1794.
45. Sugiyama M, Bhawal UK, Kawamura M et al. Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br. J. Oral Maxillofac. Surg. 2007; 45; 116-122.
46. Rischin D, Young RJ, Fisher R et al. Prognostic significance of p16INK4a and human papillomvirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J. Clin. Oncol. 2010; 28; 4142-4148.